Concepedia

Chester Kao

CK

11

Publications

375

Citations

11

H-Index

2016

Active since

Affiliations

Duke Medical Center(Current)

Duke Cancer Institute

Johns Hopkins University

Johns Hopkins Medicine

Sidney Kimmel Comprehensive Cancer Center

Chester Kao is an author at Duke Medical Center specializing in medicine, oncology, and radiation oncology.

ORCID

Top concepts

Publications per year

2016–2025

11

Publications

11

<i>LRP1B</i> mutations are associated with favorable outcomes to immune checkpoint inhibitors across multiple cancer types

Landon C. Brown, Matthew D. Tucker, Ramy Sedhom et al. · Journal for ImmunoTherapy of Cancer · 2021 · 109 citations · Full text

High Expression of miR-532-5p, a Tumor Suppressor, Leads to Better Prognosis in Ovarian Cancer Both <i>In Vivo</i> and <i>In Vitro</i>

Fan Wang, Jeremy Chang, Chester Kao et al. · Molecular Cancer Therapeutics · 2016 · 56 citations · Full text

, , +14

Association of baseline neutrophil-to-eosinophil ratio with response to nivolumab plus ipilimumab in patients with metastatic renal cell carcinoma

Matthew D. Tucker, Landon C. Brown, Yu‐Wei Chen et al. · Biomarker Research · 2021 · 41 citations · Full text

Predictive Value of Combining Biomarkers for Clinical Outcomes in Advanced Non-Small Cell Lung Cancer Patients Receiving Immune Checkpoint Inhibitors

Chester Kao, Eric R. Powers, Yuan Wu et al. · Clinical Lung Cancer · 2021 · 30 citations · Full text

Salvage Ipilimumab plus Nivolumab after Anti-PD-1/PD-L1 Therapy in Advanced Hepatocellular Carcinoma

Stephanie Alden, Mir Lim, Chester Kao et al. · Cancer Research Communications · 2023 · 29 citations · Full text

Rows per page

1–5 of 11